G. Guarneri

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

Oral nanotherapeutic formulation of insulin with reduced episodes of hypoglycaemia

Nonalcoholic fatty liver disease (NAFLD) in nonobese patients with diabetes: Prevalence and relationships with hemodynamic alterations detected with Doppler sonography

Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life